Hikma Pharmaceuticals (GB:HIK) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hikma Pharmaceuticals PLC has announced that as of June 30, 2024, the company’s issued share capital consists of 221,886,453 Ordinary Shares, each with voting rights, excluding the 12,833,233 Shares held in treasury which do not carry voting rights. Shareholders can use this total figure as a basis for reporting changes in ownership or interest in the company.
For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.